Showing results (511-520 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|August 6, 2005
Suppression of MUC1 synthesis downregulates expression of the epidermal growth factor receptorXiaojing Li, Li Wang, David P Nunes, et al.Cancer Biology & Therapy|April 18, 2007
The inhibitory effects of nanosize delivery system for antisense oligonucleotide of hTERT on EC9706 cellsZhenzhong Zhang, Baiyan Wang, Huixiang Li, et al.Cancer Biology & Therapy|January 17, 2007
Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone diseaseSachchida Nand Pandey, Dinesh Raj Modi, Gourdas Choudhuri, et al.Cancer Biology & Therapy|January 17, 2007
Bortezomib sensitizes human head and neck carcinoma cells SQ20B to radiationCharles N Weber, George J Cerniglia, Amit Maity, et al.Cancer Biology & Therapy|May 31, 2007
Cationic lipid complexed camptothecin (EndoTAG-2) improves antitumoral efficacy by tumor vascular targetingM E Eichhorn, S Luedemann, S Strieth, et al.Cancer Biology & Therapy|May 31, 2007
The pathology of tumor stromatogenesisAlexandra Giatromanolaki, Efthimios Sivridis, Michael I KoukourakisCancer Biology & Therapy|April 26, 2007
Hsp60 and Hspl0 as antitumor molecular agentsFrancesco Cappello, Anna M Czarnecka, Giampiero La Rocca, et al.Cancer Biology & Therapy|January 16, 2023
Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinomaMinxiao Chen, Chenchen Qian, Bo Jin, et al.Cancer Biology & Therapy|January 2, 2023
Combination of metformin/efavirenz/fluoxetine exhibits profound anticancer activity via a cancer cell-specific ROS amplificationBeom-Goo Kang, Madhuri Shende, Gozde Inci, et al.Cancer Biology & Therapy|November 12, 2019
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A lossDaniele Frisone, Melinda Charrier, Sophie Clement, et al.Pageof 387